Find clinical trials for COVID-19 in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections

Communicable Diseases

Coronavirus Infections

Pneumonia

Post-Acute COVID-19 Syndrome

Syndrome

Human Influenza

COVID-19 trials near Houston, TX, USA:

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

The goal of this cluster randomized clinical trial is to test the efficacy of messaging interventions to increase booster vaccine uptake in adults in...

Enrolling

COVID-19

Behavioral: Vaccine Acceptance Question

Behavioral: Vaccine Messaging

University of California San Francisco (UCSF)

Houston, Texas, United States and 6 other locations

Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection (RESERVOIR)

This is a 2-part, 2-arm, Phase 2 , multicentre, randomized, double-blind, placebo-controlled study in adults with COVID-19 with gas...

Active, not recruiting

Covid19

Drug: Placebo

Drug: Niclosamide

Phase 2

First Wave BioPharma

Webster, Texas, United States and 24 other locations

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting

COVID-19

Biological: Placebo

Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)

Houston, Texas, United States and 123 other locations

Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial

Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...

Enrolling

Covid19

Drug: STRI Formula

Drug: Placebo

Phase 2

Eyecheck

Houston, Texas, United States and 12 other locations

Electrical Stimulation for Post Acute COVID-19 Syndrome (PACS)

feasibility. Eligible participants will be screened at the BCM Post-COVID-19 Clinic for inclusion criteria. Participants, who satis...

Enrolling

COVID-19

Muscle Weakness

Device: Electrical Stimulation - Active

Device: Electrical Stimulation - Placebo

Baylor College of Medicine

Houston, Texas, United States

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...

Enrolling

COVID-19

Device: RD-X19

Device: Sham

EmitBio

Houston, Texas, United States and 47 other locations

Study of LAU-7b for the Treatment of COVID-19 Disease in Adults (RESOLUTION)

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting

COVID-19 Disease

Drug: Placebo oral capsule

Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Houston, Texas, United States and 28 other locations

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (BOSS-002)

in treating high-risk participants who have tested positive for Covid-19. The main question[s] it aims to answer are:To evaluate th-...

Enrolling

COVID-19

Other: Placebo

Drug: NP-101

Phase 2

Novatek Pharmaceuticals

Houston, Texas, United States of America and 3 other locations

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...

Active, not recruiting

COVID-19

Influenza, Human

Other: Normal saline placebo

Biological: BNT162b2 (Omi XBB.1.5)

Phase 2

Pfizer

Houston, Texas, United States and 29 other locations

A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER)

study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID...

Enrolling

Covid19

Corona Virus Infection

Drug: Baricitinib

Phase 3